Viiv Healthcare Company

FDA Regulatory Profile

Viiv Healthcare Company appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-1185-2014, Class III) was initiated on February 11, 2014.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1185-2014Class IIITivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRFebruary 11, 2014